About
A new book, FOR BLOOD AND MONEY, tells the story of the biotech boom and two of the greatest biotech trades of all time. MarketWatch's biopharma writer Jaimy Lee talks to the book's author, MarketWatch Managing Editor Nathan Vardi, about the golden age of biotech investing and whether or not it's over.

Presenters
1673039311-96b3b1576052e541
Nathan Vardi
Managing Editor for Enterpris, MarketWatch
Nathan Vardi is MarketWatch's managing editor for enterprise, driving features, long-form and investigative journalism across the business news site. Previously, Nathan was a senior editor at Forbes. He is currently writing "For Blood and Money," a book about cancer drug development, to be published by W.W. Norton & Co.
1673039488-6cdad530c5dcf5c6
Jaimy Lee
Health Editor, MarketWatch
Jaimy Lee has more than 15 years of experience covering healthcare, pharmaceuticals, and the business of medicine. She is the health editor at MarketWatch and has previously held editing and reporting roles at LinkedIn, Modern Healthcare, and Medical Marketing + Media.
Register To Watch Recording
Full name*
Email Address*
Seniority*
Company*
Have a question for the speakers? Submit here.
Marketing Permission
By registering, I agree to communications from Barron's Group. I understand that I can unsubscribe at any time by clicking the unsubscribe link in the footer of our emails, or by replying to our emails and asking to be unsubscribed. For more information, please read our privacy notice.
Privacy Notice
✓ Yes, I would like to receive communications from Barron's Group.
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.